Search Results - "Gartenhaus, Ronald B."

Refine Results
  1. 1

    Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL by Kapadia, Bandish, Nanaji, Nahid M., Bhalla, Kavita, Bhandary, Binny, Lapidus, Rena, Beheshti, Afshin, Evens, Andrew M., Gartenhaus, Ronald B.

    Published in Nature communications (26-02-2018)
    “…Altered lipid metabolism and aberrant protein translation are strongly associated with cancerous outgrowth; however, the inter-regulation of these key…”
    Get full text
    Journal Article
  2. 2

    Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice by Heredia, Alonso, Nhut Le, Ronald B. Gartenhaus, Edward Sausville, Sandra Medina-Moreno, Juan C. Zapata, Charles Davis, Robert C. Gallo, Robert R. Redfield

    “…Most HIV antiretrovirals target viral proteins. Unfortunately, HIV mutates under drug pressure, which can lead to drug resistance. Targeting cellular proteins…”
    Get full text
    Journal Article
  3. 3

    Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma by Kayastha, Forum, Herrington, Noah B, Kapadia, Bandish, Roychowdhury, Anirban, Nanaji, Nahid, Kellogg, Glen E, Gartenhaus, Ronald B

    Published in Molecular medicine (Cambridge, Mass.) (04-09-2022)
    “…Deregulated translation initiation is implicated extensively in cancer initiation and progression. It is actively pursued as a viable target that circumvents…”
    Get full text
    Journal Article
  4. 4

    Targeting the translational machinery as a novel treatment strategy for hematologic malignancies by Hagner, Patrick R., Schneider, Abraham, Gartenhaus, Ronald B.

    Published in Blood (18-03-2010)
    “…The dysregulation of protein synthesis evident in the transformed phenotype has opened up a burgeoning field of research in cancer biology. Translation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) by Mazan-Mamczarz, Krystyna, Gartenhaus, Ronald B

    Published in Leukemia research (01-11-2013)
    “…Abstract MicroRNAs (miRNAs) are small endogenous RNA molecules that regulate gene expression at the post-transcriptional level through its sequence…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma by Beheshti, Afshin, Vanderburg, Charles, McDonald, J Tyson, Ramkumar, Charusheila, Kadungure, Tatenda, Zhang, Hong, Gartenhaus, Ronald B, Evens, Andrew M

    Published in PloS one (20-01-2017)
    “…Extensive epidemiological data have demonstrated an exponential rise in the incidence of non-Hodgkin lymphoma (NHL) that is associated with increasing age. The…”
    Get full text
    Journal Article
  9. 9

    Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development by Mazan-Mamczarz, Krystyna, Zhao, X Frank, Dai, Bojie, Steinhardt, James J, Peroutka, Raymond J, Berk, Kimberly L, Landon, Ari L, Sadowska, Mariola, Zhang, Yongqing, Lehrmann, Elin, Becker, Kevin G, Shaknovich, Rita, Liu, Zhenqiu, Gartenhaus, Ronald B

    Published in PLoS genetics (01-01-2014)
    “…Deregulation of the translational machinery is emerging as a critical contributor to cancer development. The contribution of microRNAs in translational gene…”
    Get full text
    Journal Article
  10. 10

    The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma by Bhalla, Savita, Evens, Andrew M., Dai, Bojie, Prachand, Sheila, Gordon, Leo I., Gartenhaus, Ronald B.

    Published in Blood (28-07-2011)
    “…The RAS/RAF/MEK/ERK signaling pathway has been largely unexplored as a potential therapeutic target in lymphoma. The novel 2nd generation anti-MEK small…”
    Get full text
    Journal Article
  11. 11

    Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma by Dai, Bojie, Zhao, X. Frank, Mazan-Mamczarz, Krystyna, Hagner, Patrick, Corl, Sharon, Bahassi, El Mustapha, Lu, Song, Stambrook, Peter J., Shapiro, Paul, Gartenhaus, Ronald B.

    Published in Nature communications (19-07-2011)
    “…Distinct oncogenic signalling cascades have been associated with non-Hodgkin lymphoma. ERK1/2 signalling elicits both transcriptional and post-transcriptional…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Imbalanced Matriptase Pericellular Proteolysis Contributes to the Pathogenesis of Malignant B-Cell Lymphomas by Chou, Feng-Pai, Chen, Ya-Wen, Zhao, Xianfeng F, Xu-Monette, Zijun Y, Young, Ken H, Gartenhaus, Ronald B, Wang, Jehng-Kang, Kataoka, Hiroaki, Zuo, Annie H, Barndt, Robert J, Johnson, Michael, Lin, Chen-Yong

    Published in The American journal of pathology (01-10-2013)
    “…Membrane-associated serine protease matriptase is widely expressed by epithelial/carcinoma cells in which its proteolytic activity is tightly controlled by the…”
    Get full text
    Journal Article
  14. 14

    c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas by Hu, Fang, Gartenhaus, Ronald B, Zhao, Xianfeng F, Fang, Hong-Bin, Minkove, Samuel, Poss, Daniella E, Rapoport, Aaron P

    Published in Leukemia research (01-04-2013)
    “…Abstract c-Myc has been implicated in a variety of hematologic malignancies including Burkitt's lymphoma. Targeting c-Myc driven growth pathways could be…”
    Get full text
    Journal Article
  15. 15

    ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes by Mazan-Mamczarz, Krystyna, Hagner, Patrick R., Zhang, Yongqing, Dai, Bojie, Lehrmann, Elin, Becker, Kevin G., Keene, Jack D., Gorospe, Myriam, Liu, Zhenqui, Gartenhaus, Ronald B.

    Published in Blood (24-02-2011)
    “…Maintenance of genomic stability depends on the DNA damage response, a biologic barrier in early stages of cancer development. Failure of this response results…”
    Get full text
    Journal Article
  16. 16

    AMPK signaling: A targetable tumor suppressor pathway? by Schneider, Abraham, Gartenhaus, Ronald B.

    Published in Cancer biology & therapy (01-12-2010)
    “…Commentary to: AMPK as a therapeutic target in renal cell carcinoma Jennifer Woodard, Sonali Joshi, Benoit Viollet, Nissim Hay and Leonidas C. Platanias…”
    Get full text
    Journal Article
  17. 17

    Kernel based methods for accelerated failure time model with ultra-high dimensional data by Liu, Zhenqiu, Chen, Dechang, Tan, Ming, Jiang, Feng, Gartenhaus, Ronald B

    Published in BMC bioinformatics (21-12-2010)
    “…Most genomic data have ultra-high dimensions with more than 10,000 genes (probes). Regularization methods with L₁ and L(p) penalty have been extensively…”
    Get full text
    Journal Article
  18. 18

    The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation by Vitolo, Michele I., Anglin, Ian E., Mahoney, William M., Renoud, Keli J., Gartenhaus, Ronald B., Bachman, Kurtis E., Passaniti, Antonino

    Published in Cancer biology & therapy (01-06-2007)
    “…The Runt box domain DNA-binding transcription factors (RUNX) play key roles in hematopoietic, bone, and gastric development. These factors regulate…”
    Get full text
    Journal Article
  19. 19

    Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells by Evens, Andrew M., Lecane, Philip, Magda, Darren, Prachand, Sheila, Singhal, Seema, Nelson, Jeff, Miller, Richard A., Gartenhaus, Ronald B., Gordon, Leo I.

    Published in Blood (01-02-2005)
    “…Motexafin gadolinium (MGd), an expanded porphyrin, is a tumor-selective redox-mediator that reacts with many intracellular reducing metabolites. Because redox…”
    Get full text
    Journal Article
  20. 20

    Gene and pathway identification with Lp penalized Bayesian logistic regression by Liu, Zhenqiu, Gartenhaus, Ronald B, Tan, Ming, Jiang, Feng, Jiao, Xiaoli

    Published in BMC bioinformatics (03-10-2008)
    “…Identifying genes and pathways associated with diseases such as cancer has been a subject of considerable research in recent years in the area of…”
    Get full text
    Journal Article